High-Potency Drug Manufacturing: Why Containment Strategy Matters in Oncology Production
Introduction Modern oncology therapies are becoming increasingly specialized, and so are the manufacturing environments required to produce them. For pharmaceutical companies developing potent or cytotoxic products, conventional manufacturing controls may not be enough. The facility, equipment, processes and people must operate within a carefully designed containment strategy. That makes high-potency pharmaceutical manufacturing fundamentally different from […]